​

Neogen (NEOG) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NEOG Stock Forecast

Neogen (NEOG) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $13.00, with a high of $13.00 and a low of $13.00. This represents a 9.06% increase from the last price of $11.92.

$11 $13 $15 $17 $19 $21 High: $13 Avg: $13 Low: $13 Last Closed Price: $11.92

NEOG Stock Rating

Neogen stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (45.45%), 5 Hold (45.45%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 5 5 Strong Sell Sell Hold Buy Strong Buy

NEOG Price Target Upside V Benchmarks

TypeNameUpside
StockNeogen9.06%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks21.93%

Price Target Trends

1M3M12M
# Anlaysts-14
Avg Price Target-$13.00$10.38
Last Closing Price$11.92$11.92$11.92
Upside/Downside-9.06%-12.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26211--4
Aug, 26112--4
Jul, 26112--4
Jun, 26112--4
May, 26112--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 03, 2026Piper Sandler$13.00$12.047.97%9.06%
Jan 12, 2026David WestenbergPiper Sandler$10.00$9.277.87%-16.11%
Jan 09, 2026Guggenheim$12.00$9.7123.58%0.67%
Oct 16, 2025David WestenbergPiper Sandler$6.50$5.959.24%-45.47%
Apr 22, 2025David WestenbergPiper Sandler$5.00$4.755.26%-58.05%
Aug 06, 2024David WestenbergPiper Sandler$17.50$16.158.36%46.81%
Dec 14, 2022David WestenbergPiper Sandler$17.00$15.3510.75%42.62%
Oct 09, 2022David WestenbergPiper Sandler$14.00$12.6810.41%17.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 26, 2026Piper SandlerNeutralOverweightupgrade
Aug 03, 2026Piper SandlerNeutralNeutralhold
Mar 02, 2026William BlairMarket PerformMarket Performhold
Jan 12, 2026Piper SandlerNeutralNeutralhold
Jan 09, 2026GuggenheimBuyBuyhold
Dec 10, 2025CJS SecuritiesMarket PerformOutperformupgrade
Oct 16, 2025Piper SandlerNeutralNeutralhold
Sep 29, 2025CJS SecuritiesMarket Performinitialise
Apr 22, 2025Piper SandlerNeutralNeutralhold
Dec 19, 2024GuggenheimBuyinitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 22May 23May 24May 25May 26May 27May 28May 29
Reported$0.45$-0.12$-0.04$-5.03$-0.04---
Avg Forecast$0.43$0.08$-0.03$-2.14$0.02$0.09$0.16-
High Forecast$0.43$0.08$-0.03$-1.96$0.02$0.22$0.16-
Low Forecast$0.42$0.08$-0.03$-2.28$0.02$-0.16$0.15-
Surprise %4.65%-250.00%33.33%135.05%-300.00%---

Revenue Forecast

$500M $630M $760M $890M $1B $1B May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 22May 23May 24May 25May 26May 27May 28May 29
Reported$527.16M$822.45M$924.22M$894.66M$870.40M---
Avg Forecast$526.70M$808.35M$913.27M$918.10M$960.20M$1.00B$1.04B$1.09B
High Forecast$529.77M$819.27M$914.91M$934.39M$982.93M$1.01B$1.05B$1.10B
Low Forecast$524.03M$798.12M$910.70M$906.21M$941.55M$997.38M$1.03B$1.07B
Surprise %0.09%1.74%1.20%-2.55%-9.35%---

Net Income Forecast

$-2B $-1B $-700M $-300M $100M $500M May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 22May 23May 24May 25May 26May 27May 28May 29
Reported$48.31M$-22.87M$-9.42M$-1.09B$-7.90M---
Avg Forecast$60.33M$17.32M$11.78M$-470.14M$3.79M$9.89M$33.55M-
High Forecast$72.40M$17.62M$14.13M$-425.16M$3.98M$46.71M$34.14M-
Low Forecast$48.27M$17.03M$9.42M$-492.80M$3.59M$-33.97M$33.00M-
Surprise %-19.93%-232.05%-179.99%132.28%-308.53%---

NEOG Forecast FAQ

Is Neogen stock a buy?

Neogen stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Neogen is a favorable investment for most analysts.

What is Neogen's price target?

Neogen's price target, set by 11 Wall Street analysts, averages $13 over the next 12 months. The price target range spans from $13 at the low end to $13 at the high end, suggesting a potential 9.06% change from the previous closing price of $11.92.

How does Neogen stock forecast compare to its benchmarks?

Neogen's stock forecast shows a 9.06% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (21.93%).

What is the breakdown of analyst ratings for Neogen over the past three months?

  • September 2026: 50.00% Strong Buy, 25.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Neogen’s EPS forecast?

Neogen's average annual EPS forecast for its fiscal year ending in May 2027 is $0.09, marking a -325.00% decrease from the reported $-0.04 in 2026. Estimates for the following years are $0.16 in 2028, and $0 in 2029.

What is Neogen’s revenue forecast?

Neogen's average annual revenue forecast for its fiscal year ending in May 2027 is $1B, reflecting a 15.41% increase from the reported $870.4M in 2026. The forecast for 2028 is $1.04B, and $1.09B for 2029.

What is Neogen’s net income forecast?

Neogen's net income forecast for the fiscal year ending in May 2027 stands at $9.89M, representing a -225.24% decrease from the reported $-7.9M in 2026. Projections indicate $33.55M in 2028, and $0 in 2029.